STOCK TITAN

[Form 4] Sera Prognostics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Sera Prognostics insider sale by Chief Data Officer — The reporting person, Paul Kearney, executed a sale of 1,458 shares of Class A common stock on 09/02/2025 at a reported price of $3.49 per share. After the sale, the filing shows the reporting person beneficially owns 176,940 shares. The filing states the sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2025, and the Form 4 was submitted by an attorney-in-fact.

Vendita di titoli di Sera Prognostics da parte del Chief Data Officer — Il soggetto dichiarato, Paul Kearney, ha venduto 1.458 azioni di azioni ordinarie di classe A il 02/09/2025 al prezzo riportato di $3,49 per azione. Dopo la vendita, la dichiarazione indica che il soggetto beneficiario detiene 176.940 azioni. Nel modulo si precisa che la vendita è avvenuta in base a un piano di negoziazione Rule 10b5-1 adottato dal dichiarante il 21 maggio 2025, e il Modulo 4 è stato inviato da un procuratore.

Venta interna de Sera Prognostics por parte del Chief Data Officer — La persona informante, Paul Kearney, ejecutó la venta de 1.458 acciones de acciones ordinarias Clase A el 02/09/2025 a un precio informado de $3.49 por acción. Tras la operación, el documento refleja que la persona informante posee de forma beneficiaria 176.940 acciones. El informe indica que la venta se realizó conforme a un plan de negociación Rule 10b5-1 adoptado por la persona informante el 21 de mayo de 2025, y que el Formulario 4 fue presentado por un apoderado.

수석 데이터 책임자에 의한 Sera Prognostics 내부자 매도 — 보고인인 Paul Kearney는 2025-09-02에 클래스 A 보통주 1,458주를 주당 보고가 $3.49에 매도했습니다. 매도 후 해당 보고인은 176,940주를 실질적으로 보유하고 있는 것으로 신고되어 있습니다. 서류에는 이 매도가 보고인이 2025년 5월 21일 채택한 Rule 10b5-1 거래계획에 따라 이루어졌으며, Form 4는 대리인에 의해 제출되었다고 적혀 있습니다.

Vente par un initié de Sera Prognostics réalisée par le Chief Data Officer — La personne déclarante, Paul Kearney, a cédé 1 458 actions d'actions ordinaires de catégorie A le 02/09/2025 au prix déclaré de 3,49 $ par action. Après la vente, le dossier indique que la personne déclarante détient à titre bénéficiaire 176 940 actions. Le dépôt précise que la vente a été effectuée en vertu d'un plan de négociation Rule 10b5-1 adopté par la personne déclarante le 21 mai 2025, et que le formulaire 4 a été soumis par un mandataire.

Insider-Verkauf bei Sera Prognostics durch den Chief Data Officer — Die meldende Person, Paul Kearney, veräußerte am 02.09.2025 1.458 Aktien der Stammaktien Klasse A zu einem gemeldeten Preis von $3,49 pro Aktie. Nach dem Verkauf weist die Einreichung aus, dass die meldende Person wirtschaftlich 176.940 Aktien hält. In der Meldung heißt es, der Verkauf erfolgte im Rahmen eines am 21. Mai 2025 vom Melder übernommenen Rule 10b5-1-Handelsplans, und das Formular 4 wurde von einem Bevollmächtigten eingereicht.

Positive
  • Sale executed under a Rule 10b5-1 trading plan, indicating a pre-authorized and compliant process
  • Reporting person retains substantial beneficial ownership at 176,940 shares after the sale
Negative
  • Disposition of 1,458 shares reduces the officer's stake, which may be viewed negatively by some investors

Insights

TL;DR: Officer sold a small block under a 10b5-1 plan; remaining stake remains substantial.

The reported disposal of 1,458 shares at $3.49 appears routine and was executed under a pre-established 10b5-1 plan, which typically signals automated, pre-authorized selling rather than ad-hoc insider activity. The post-transaction beneficial ownership of 176,940 shares indicates the officer retains material exposure to the company's equity. This transaction alone is not a material capital event for SERA absent other insider activity or concurrent disclosures.

TL;DR: Use of a 10b5-1 plan demonstrates compliance with insider trading rules but reduces insider holdings slightly.

The disclosure explicitly cites a Rule 10b5-1 trading plan adopted May 21, 2025, which helps establish an affirmative defense to insider trading allegations. The filing is signed by an attorney-in-fact, indicating procedural handling by a designated agent. From a governance perspective the transaction is compliant and routine; its investor impact depends on the officer's remaining stake and any pattern of future trades.

Vendita di titoli di Sera Prognostics da parte del Chief Data Officer — Il soggetto dichiarato, Paul Kearney, ha venduto 1.458 azioni di azioni ordinarie di classe A il 02/09/2025 al prezzo riportato di $3,49 per azione. Dopo la vendita, la dichiarazione indica che il soggetto beneficiario detiene 176.940 azioni. Nel modulo si precisa che la vendita è avvenuta in base a un piano di negoziazione Rule 10b5-1 adottato dal dichiarante il 21 maggio 2025, e il Modulo 4 è stato inviato da un procuratore.

Venta interna de Sera Prognostics por parte del Chief Data Officer — La persona informante, Paul Kearney, ejecutó la venta de 1.458 acciones de acciones ordinarias Clase A el 02/09/2025 a un precio informado de $3.49 por acción. Tras la operación, el documento refleja que la persona informante posee de forma beneficiaria 176.940 acciones. El informe indica que la venta se realizó conforme a un plan de negociación Rule 10b5-1 adoptado por la persona informante el 21 de mayo de 2025, y que el Formulario 4 fue presentado por un apoderado.

수석 데이터 책임자에 의한 Sera Prognostics 내부자 매도 — 보고인인 Paul Kearney는 2025-09-02에 클래스 A 보통주 1,458주를 주당 보고가 $3.49에 매도했습니다. 매도 후 해당 보고인은 176,940주를 실질적으로 보유하고 있는 것으로 신고되어 있습니다. 서류에는 이 매도가 보고인이 2025년 5월 21일 채택한 Rule 10b5-1 거래계획에 따라 이루어졌으며, Form 4는 대리인에 의해 제출되었다고 적혀 있습니다.

Vente par un initié de Sera Prognostics réalisée par le Chief Data Officer — La personne déclarante, Paul Kearney, a cédé 1 458 actions d'actions ordinaires de catégorie A le 02/09/2025 au prix déclaré de 3,49 $ par action. Après la vente, le dossier indique que la personne déclarante détient à titre bénéficiaire 176 940 actions. Le dépôt précise que la vente a été effectuée en vertu d'un plan de négociation Rule 10b5-1 adopté par la personne déclarante le 21 mai 2025, et que le formulaire 4 a été soumis par un mandataire.

Insider-Verkauf bei Sera Prognostics durch den Chief Data Officer — Die meldende Person, Paul Kearney, veräußerte am 02.09.2025 1.458 Aktien der Stammaktien Klasse A zu einem gemeldeten Preis von $3,49 pro Aktie. Nach dem Verkauf weist die Einreichung aus, dass die meldende Person wirtschaftlich 176.940 Aktien hält. In der Meldung heißt es, der Verkauf erfolgte im Rahmen eines am 21. Mai 2025 vom Melder übernommenen Rule 10b5-1-Handelsplans, und das Formular 4 wurde von einem Bevollmächtigten eingereicht.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kearney Paul

(Last) (First) (Middle)
C/O SERA PROGNOSTICS, INC.
2749 EAST PARLEYS WAY, SUITE 200

(Street)
SALT LAKE CITY UT 84109

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SERA PROGNOSTICS, INC. [ SERA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Data Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/02/2025 S(1) 1,458 D $3.49 176,940 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2025.
/s/ Benjamin G. Jackson, Attorney-in-fact 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SERA insider Paul Kearney sell?

The filing reports a sale of 1,458 shares of Class A common stock at $3.49 per share.

When was the insider transaction executed for SERA?

The transaction date reported on the Form 4 is 09/02/2025.

Was the sale by the SERA officer part of a trading plan?

Yes, the Form 4 states the sale was made pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025.

How many SERA shares does the reporting person own after the sale?

The filing shows 176,940 shares beneficially owned following the reported transaction.

Who signed the Form 4 for the SERA filing?

The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

122.94M
32.84M
10.87%
64.98%
3.27%
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY